An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model
DNA-delivered monoclonal antibodies (DMAbs) can be produced by muscle cells in vivo, potentially allowing prevention or treatment of infectious diseases. Here, the authors show that two DMAbs targeting Pseudomonas aeruginosa proteins confer protection against lethal pneumonia in mice.
Guardado en:
Autores principales: | Ami Patel, Antonio DiGiandomenico, Ashley E. Keller, Trevor R. F. Smith, Daniel H. Park, Stephanie Ramos, Katherine Schultheis, Sarah T. C. Elliott, Janess Mendoza, Kate E. Broderick, Megan C. Wise, Jian Yan, Jingjing Jiang, Seleeke Flingai, Amir S. Khan, Kar Muthumani, Laurent Humeau, Lily I. Cheng, Leslie Wachter-Rosati, C. Kendall Stover, Niranjan Y. Sardesai, David B. Weiner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5cc6f71f1078455d97d037b4f8457a6b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections
por: Sarah T. C. Elliott, et al.
Publicado: (2017) -
A new approach to produce IgG4-like bispecific antibodies
por: Caizhi Zhao, et al.
Publicado: (2021) -
Efficient generation of bispecific IgG antibodies by split intein mediated protein trans-splicing system
por: Lei Han, et al.
Publicado: (2017) -
Human milk IgGs contain various combinations of different antigen-binding sites resulting in multiple variants of their bispecificity.
por: Sergey E Sedykh, et al.
Publicado: (2012) -
Production of IgG1-based bispecific antibody without extra cysteine residue via intein-mediated protein trans-splicing
por: Hiroki Akiba, et al.
Publicado: (2021)